Search research articles
Contact Us
Filters
Showing results (151-160 of 182) with videos related to
Page
of 19
Sort By:
Circulation
|
August 8, 2019
Myocarditis in the Setting of Cancer Therapeutics: Proposed Case Definitions for Emerging Clinical Syndromes in Cardio-Oncology
Marc P Bonaca, Benjamin A Olenchock, Joe-Elie Salem, et al.
Rheumatology (Oxford, England)
|
November 26, 2024
Prognostic factors for patients with cancer-associated dermatomyositis: a retrospective, multicentre cohort study of 73 patients
Alexandre Teboul, Yves Allenbach, Florence Tubach, et al.
Brain : a Journal of Neurology
|
April 19, 2016
High risk of cancer in autoimmune necrotizing myopathies: usefulness of myositis specific antibody
Yves Allenbach, Jeremy Keraen, Anne-Marie Bouvier, et al.
Skeletal Muscle
|
December 15, 2015
CD49d is a disease progression biomarker and a potential target for immunotherapy in Duchenne muscular dystrophy
Fernanda Pinto-Mariz, Luciana Rodrigues Carvalho, Alexandra Prufer De Queiroz Campos Araujo, et al.
Brain Communications
|
June 30, 2023
Neurological outcomes in immune checkpoint inhibitor-related neurotoxicity
Antonio Farina, Cristina Birzu, Mad-Hélénie Elsensohn, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
April 13, 2019
Expanding the spectrum of HIV-associated myopathy
Océane Landon-Cardinal, Laure Gallay, Odile Dubourg, et al.
Rheumatology (Oxford, England)
|
March 2, 2024
Inclusion-body myositis associated with Sjögren's disease: clinical characteristics and comparison with other Sjögren-associated myositis
Quentin Astouati, Thomas Machet, Camille Houssais, et al.
Annals of the Rheumatic Diseases
|
April 25, 2020
EULAR points to consider for the diagnosis and management of rheumatic immune-related adverse events due to cancer immunotherapy with checkpoint inhibitors
Marie Kostine, Axel Finckh, Clifton O Bingham, et al.
Autoimmunity Reviews
|
March 13, 2026
Clinical characteristics and cancer risk of anti-OJ antisynthetase syndrome: A cohort comparative study and a systematic literature review
Valentin Pillot, Segolene Toquet, Jean Luc Charuel, et al.
Cell Death & Disease
|
June 12, 2026
Inflammation reprograms fibro-adipogenic progenitors to sustain immunopathogenic niches in myositis
Christopher Nelke, Julian Sanchez-Dal Cin, Charles-Antoine Dallevet, et al.
Page
of 19
Search research articles
Search
Showing results (151-160 of 182) with videos related to
Sort By:
Page
of 19
Circulation
|
August 8, 2019
Myocarditis in the Setting of Cancer Therapeutics: Proposed Case Definitions for Emerging Clinical Syndromes in Cardio-Oncology
Marc P Bonaca, Benjamin A Olenchock, Joe-Elie Salem, et al.
Rheumatology (Oxford, England)
|
November 26, 2024
Prognostic factors for patients with cancer-associated dermatomyositis: a retrospective, multicentre cohort study of 73 patients
Alexandre Teboul, Yves Allenbach, Florence Tubach, et al.
Brain : a Journal of Neurology
|
April 19, 2016
High risk of cancer in autoimmune necrotizing myopathies: usefulness of myositis specific antibody
Yves Allenbach, Jeremy Keraen, Anne-Marie Bouvier, et al.
Skeletal Muscle
|
December 15, 2015
CD49d is a disease progression biomarker and a potential target for immunotherapy in Duchenne muscular dystrophy
Fernanda Pinto-Mariz, Luciana Rodrigues Carvalho, Alexandra Prufer De Queiroz Campos Araujo, et al.
Brain Communications
|
June 30, 2023
Neurological outcomes in immune checkpoint inhibitor-related neurotoxicity
Antonio Farina, Cristina Birzu, Mad-Hélénie Elsensohn, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
April 13, 2019
Expanding the spectrum of HIV-associated myopathy
Océane Landon-Cardinal, Laure Gallay, Odile Dubourg, et al.
Rheumatology (Oxford, England)
|
March 2, 2024
Inclusion-body myositis associated with Sjögren's disease: clinical characteristics and comparison with other Sjögren-associated myositis
Quentin Astouati, Thomas Machet, Camille Houssais, et al.
Annals of the Rheumatic Diseases
|
April 25, 2020
EULAR points to consider for the diagnosis and management of rheumatic immune-related adverse events due to cancer immunotherapy with checkpoint inhibitors
Marie Kostine, Axel Finckh, Clifton O Bingham, et al.
Autoimmunity Reviews
|
March 13, 2026
Clinical characteristics and cancer risk of anti-OJ antisynthetase syndrome: A cohort comparative study and a systematic literature review
Valentin Pillot, Segolene Toquet, Jean Luc Charuel, et al.
Cell Death & Disease
|
June 12, 2026
Inflammation reprograms fibro-adipogenic progenitors to sustain immunopathogenic niches in myositis
Christopher Nelke, Julian Sanchez-Dal Cin, Charles-Antoine Dallevet, et al.
Page
of 19